U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
The U.S. pancreatic cancer diagnostics market is projected to register a healthy CAGR of 8.3% in the forecast period of 2022 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2030.
Market SegmentationU.S. Pancreatic Cancer Diagnostics Market, By Test Type (Imaging Test, Biopsy, Blood Test, Genomic Test, and Others), Cancer Stage (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Tumor Type (Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluoroimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, and Others), Application (Screening, Diagnostic and Predictive, Prognostic, and Research), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Region (Southern U.S., Western U.S., Mid-Western U.S., and North-Eastern U.S.) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the U.S. pancreatic cancer diagnostics market are:• Novel technological advancements in pancreatic diagnostics
• Growing awareness of pancreatic cancer and increasing healthcare expenditure
Market PlayersSome of the major market players operating in the U.S. pancreatic cancer diagnostics market are:• Agilent Technologies, Inc.
• BD
• Biological Dynamics
• CANON MEDICAL SYSTEMS CORPORATION
• ClearNote Health
• CTK Biotech, Inc.
• Danaher.
• Exact Sciences Corporation
• F. Hoffman- La Roche Ltd
• FUJIFILM Holdings America Corporation
• GRAIL
• Immunovia
• Koninklijke Philips N.V.
• Laboratory Corporation of America Holdings
• MP BIOMEDICALS
• Myriad Genetics, Inc.
• QIAGEN
• Quest Diagnostics Incorporated
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.